ALLIANZ-WORLDWIDE-CARE
Allianz Worldwide Care is pleased to announce the appointment of a leading industry expert to the role of Director of Sales and Marketing. Alexis Obligi, a French citizen, joined Allianz Worldwide Care this month from Henner, where he was Deputy Managing Director of International & Corporate Business Development. Alongside his role overseeing Sales and Marketing activities, Alexis will also join the Executive Committee of Allianz Worldwide Care.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151005005803/en/
Allianz Worldwide Care, the international health insurance division of Allianz Worldwide Partners, provides health, life and disability insurance and corporate assistance services to clients and insurance partners on a global scale. Allianz Worldwide Care’s client portfolio includes many of the Fortune Global 500 companies and the company also offers Intergovernmental Organisations (IGOs) and Non-Governmental Organisations (NGOs) cover for a range of insurance risks.
Alexis Obligi commented, “Following the 2014 merger of Allianz Worldwide Care Limited with the international divisions of Allianz France, this is a particularly exciting time to join Allianz Worldwide Care, a company that has shown significant, consistent growth, year on year. Allianz Worldwide Care stands out in the fast-paced international private health and life insurance industry for its international scale and client driven focus that is complemented by an incredible level of dynamism.
“I am looking forward to leading the Sales and Marketing teams in building on the successes already achieved and developing more ways to support the company’s growing client base and insurance partners, with new products and innovative services.”
//ends
About Allianz Worldwide Care
Allianz Worldwide Care is the international health and life insurance division of Allianz Worldwide Partners which serves more than 250 million beneficiaries in 34 countries and is part of the Allianz Group. Allianz Worldwide Care provides insurance solutions for health, life and disability to clients and insurance partners on a global scale. Our focus is on earning and maintaining client loyalty by providing a market leading product range, level of service and support. With a client base that includes many of the Fortune Global 500 companies, Allianz Worldwide Care continues to build a reputation for service excellence in international healthcare. www.allianzworldwidecare.com
About Allianz Worldwide Partners
Allianz Worldwide Partners is the world’s leading B2B2C specialist for expatriate health and life cover, automotive business and assistance services. Bringing together three industry experts - Allianz Worldwide Care, Allianz Global Automotive and Allianz Global Assistance - Allianz Worldwide Partners offers comprehensive integrated solutions for corporate clients by combining insurance, assistance and technology whilst providing worldwide protection and care.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151005005803/en/
Contact:
Grayling PR
Carolyn Monchouguy
carolyn.monchouguy@grayling.com
+44
(0) 7808 643 933
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Perma-Pipe International Holdings, Inc. Announces New Contract Award in Qatar27.5.2025 21:48:00 CEST | Press release
Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) today announced that it has received its first project award to be executed in Qatar since the announcement of the intent to mobilize there. The project will be for USD $2.4 million and will utilize Perma-Pipe’s fabrication capabilities and the XTRU-THERM® insulation system, a spray-applied polyurethane foam jacketed with a high-density polyethylene casing. Adham Sharkawy, Senior Vice President of Perma-Pipe’s MENA region, remarked, “In response to this important award, we will begin executing the project from a temporary facility in Doha, ensuring timely delivery and uninterrupted service to our client. Simultaneously, we are advancing the construction of our permanent facility in Qatar, which will serve as a long-term base for our regional operations. We are deeply grateful to our customers for their continued trust and confidence in Perma-Pipe’s capabilities.” Saleh Sagr, President, commented, “Expanding in Doha has been an impo
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,
LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release
~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut
The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release
The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum